Literature DB >> 10080101

Dendritic cells: a link between innate and adaptive immunity.

K Palucka1, J Banchereau.   

Abstract

Dendritic cells (DC) constitute a unique system of cells able to induce primary immune responses. As a component of the innate immune system, DC organize and transfer information from the outside world to the cells of the adaptive immune system. DC can induce such contrasting states as active immune responsiveness or immunological tolerance. Recent years have brought a wealth of information regarding DC biology and pathophysiology, that shows the complexity of this cell system. Although our understanding of DC biology is still in its infancy, we are now in a position to use DC-based immunotherapy protocols to treat cancer and infectious diseases.

Entities:  

Mesh:

Year:  1999        PMID: 10080101     DOI: 10.1023/a:1020558317162

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  111 in total

1.  Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes.

Authors:  L Zitvogel; A Regnault; A Lozier; J Wolfers; C Flament; D Tenza; P Ricciardi-Castagnoli; G Raposo; S Amigorena
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

2.  CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells.

Authors:  L J Zhou; T F Tedder
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

3.  Interleukin-12-activated natural killer cells recognize B7 costimulatory molecules on tumor cells and autologous dendritic cells.

Authors:  A B Geldhof; M Moser; L Lespagnard; K Thielemans; P De Baetselier
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

4.  CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis.

Authors:  C Caux; C Massacrier; B Vanbervliet; B Dubois; I Durand; M Cella; A Lanzavecchia; J Banchereau
Journal:  Blood       Date:  1997-08-15       Impact factor: 22.113

5.  Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma.

Authors:  A H Enk; H Jonuleit; J Saloga; J Knop
Journal:  Int J Cancer       Date:  1997-11-04       Impact factor: 7.396

Review 6.  Tumor antigens recognized by T lymphocytes.

Authors:  T Boon; J C Cerottini; B Van den Eynde; P van der Bruggen; A Van Pel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

7.  CD4+ T-cells from mice immunized to syngeneic sarcomas recognize distinct, non-shared tumor antigens.

Authors:  P A Cohen; P J Cohen; S A Rosenberg; J J Mulé
Journal:  Cancer Res       Date:  1994-02-15       Impact factor: 12.701

8.  CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells.

Authors:  D R Greaves; W Wang; D J Dairaghi; M C Dieu; B Saint-Vis; K Franz-Bacon; D Rossi; C Caux; T McClanahan; S Gordon; A Zlotnik; T J Schall
Journal:  J Exp Med       Date:  1997-09-15       Impact factor: 14.307

9.  Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells.

Authors:  I Grosjean; C Caux; C Bella; I Berger; F Wild; J Banchereau; D Kaiserlian
Journal:  J Exp Med       Date:  1997-09-15       Impact factor: 14.307

10.  Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection.

Authors:  C P Larsen; P J Morris; J M Austyn
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

View more
  53 in total

Review 1.  Dendritic cells: immune saviors or Achilles' heel?

Authors:  C W Cutler; R Jotwani; B Pulendran
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Evidence for lipopolysaccharide-induced differentiation of RAW264.7 murine macrophage cell line into dendritic like cells.

Authors:  Rajiv K Saxena; Val Vallyathan; Daniel M Lewis
Journal:  J Biosci       Date:  2003-02       Impact factor: 1.826

3.  Flt3 ligand generates morphologically distinct semimature dendritic cells in ovalbumin-sensitized mice.

Authors:  Arpita S Bharadwaj; Devendra K Agrawal
Journal:  Exp Mol Pathol       Date:  2006-12-19       Impact factor: 3.362

4.  Combined therapy of transcatheter hepatic arterial embolization with intratumoral dendritic cell infusion for hepatocellular carcinoma: clinical safety.

Authors:  Y Nakamoto; E Mizukoshi; H Tsuji; Y Sakai; M Kitahara; K Arai; T Yamashita; K Yokoyama; N Mukaida; K Matsushima; O Matsui; S Kaneko
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

Review 5.  Transcription factors in the control of dendritic cell life cycle.

Authors:  Arpita S Bharadwaj; Devendra K Agrawal
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

6.  Impaired dendritic cell function in aging leads to defective antitumor immunity.

Authors:  Annabelle Grolleau-Julius; Erin K Harning; Lisa M Abernathy; Raymond L Yung
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

7.  Induction of higher-avidity human CTLs by vector-mediated enhanced costimulation of antigen-presenting cells.

Authors:  Sixun Yang; Kwong-Yok Tsang; Jeffrey Schlom
Journal:  Clin Cancer Res       Date:  2005-08-01       Impact factor: 12.531

8.  Role of dendritic cells and alveolar macrophages in regulating early host defense against pulmonary infection with Cryptococcus neoformans.

Authors:  John J Osterholzer; Jami E Milam; Gwo-Hsiao Chen; Galen B Toews; Gary B Huffnagle; Michal A Olszewski
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

9.  Tissue microenvironment initiates an immune response to structural components of Staphylococcus aureus.

Authors:  Carine Mainzer; Thomas Packard; Sylvie Bordes; Brigitte Closs; Warner C Greene; Peter M Elias; Yoshikazu Uchida
Journal:  Exp Dermatol       Date:  2019-02       Impact factor: 3.960

10.  Novel antigen delivery technologies: a review.

Authors:  Deepika Jain; Vikas Jain; Ranjit Singh
Journal:  Drug Deliv Transl Res       Date:  2011-04       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.